Michael E Afentoulis Selected Research

Michael E Afentoulis Research Topics

3	Neoplasms (Cancer) 01/2019 - 10/2017
3	Stroke (Strokes) 11/2007 - 05/2006
2	Multiple Sclerosis 09/2006 - 07/2006
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 09/2006 - 07/2006
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2006 - 05/2006
1	Carcinoma (Carcinomatosis) 01/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2017
1	Brain Injuries (Brain Injury) 11/2007
1	Inflammation (Inflammations) 09/2006
1	Atrophy 06/2006
1	Brain Ischemia (Cerebral Ischemia) 05/2006

3	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2006
2	AntigensIBA 01/2018 - 09/2006
2	AntibodiesIBA 01/2018 - 10/2017
2	CytokinesIBA 06/2006 - 05/2006
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	VaccinesIBA 01/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Poly I-CIBA 01/2018
1	Therapeutic UsesIBA 10/2017
1	Interleukin-1beta (Interleukin 1 beta)IBA 11/2007
1	Interferon-gamma (Interferon, gamma)IBA 11/2007
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 11/2007
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2006
1	LigandsIBA 09/2006
1	myelin proteolipid protein (139-151)IBA 09/2006
1	alpha-Crystallin B ChainIBA 07/2006
1	Small Heat-Shock ProteinsIBA 07/2006
1	AnnexinsIBA 06/2006
1	Interleukin-6 (Interleukin 6)IBA 05/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2006
1	PlacebosIBA 05/2006
1	Messenger RNA (mRNA)IBA 05/2006
1	Interleukin-2 (IL2)IBA 05/2006
1	ChemokinesIBA 05/2006
1	Chemokine ReceptorsIBA 05/2006

2	Immunotherapy 01/2019 - 01/2018
2	Therapeutics 01/2018 - 09/2006